We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Paul, Weiss Achieves Victory for Edwards Lifesciences in Patent Litigation
As reported in The American Lawyer, Bloomberg News, Dow Jones and Reuters, on April 1, 2010, a federal court jury awarded Paul, Weiss client Edwards Lifesciences $74 million after it found that the Medtronic CoreValve ReValving system infringed Edwards' transcatheter heart valve patent. The invention permits a defective heart valve to be replaced with an artificial heart valve using a catheter, thus eliminating the need for open heart surgery.
The jury found the infringement to be willful, which allows Edwards to seek enhanced damages of up to three times the jury award for past infringement. In addition, Edwards will move for an injunction prohibiting future manufacture and sale of the infringing ReValving system in the United States.
The Paul, Weiss team representing Edwards Lifesciences included litigation partners John Nathan and Catherine Nyarady, counsel Kripa Raman, associates Brian Egan, Joseph Etra, Christopher Terranova and Robert Weinstock; staff attorneys Michael Pinelli, Mike Ecker, Maria Gabelica and Swatee Jasoria; and paralegals Jose Maldonado, Daniel Levi, Lori Morgan, Olu Akinyemi, Shauna Kramer and Joshua Wodin.